Page results
-
With all eyes on Paris for this summer’s Olympic Games, we look at how UCLH’s Institute of Sport, Health and Exercise (ISEH) has supported one of Britian’s Olympic hopefuls, and the care it provides for all kinds of sportspeople, from professionals to weekend warriors.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
This page tells you about having a Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
This page explains what FACETS is and how it can help you.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
File results
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions